A significant diplomatic confrontation has emerged between the United States and China regarding the financing of Nassau’s new medical facility, with both nations presenting contrasting views on the project’s implications for Bahamian sovereignty. The Chinese embassy in New Providence issued a formal rebuttal to criticism from US Ambassador Herschel Walker, characterizing the $195 million financing arrangement as a “livelihood project” developed through mutual consultation and respect.
The hospital project, which represents a substantial portion of the $278 million total financing, is being funded through preferential loan terms from China Export-Import Bank. Chinese officials emphasized that their cooperation with The Bahamas contains no hidden strategic objectives or third-party targeting, stating that the arrangement strictly addresses critical healthcare infrastructure needs while respecting the nation’s autonomous decision-making capabilities.
Ambassador Walker had previously raised concerns about the financing terms, particularly noting that Chinese law and jurisdiction would govern the loan agreement. He advocated for alternative funding options that align with international norms and confirmed that China Railway Construction Corporation, the project’s primary contractor, appears on a US restricted investment list due to its connections to China’s military-industrial apparatus.
The Bahamian government has defended its decision, explaining that the agreement underwent comprehensive technical, legal, and financial review before approval. Officials highlighted that urgent healthcare requirements—including tertiary care, maternal health services, and addressing systemic capacity shortages—outweighed other considerations. The administration also revealed that despite engaging with US financial institutions, including the US Export-Import Bank, no alternative financing package matching China’s offer in scale, timing, and certainty materialized.
Financial feasibility studies presented to Parliament indicate the facility will operate at a financial deficit, generating only 3.7% of its annual operating costs internally while requiring approximately $66 million in additional annual subsidies. However, government ministers stress that the project’s primary objective is social rather than commercial, aiming to alleviate critical healthcare shortages and improve national health outcomes despite the anticipated financial challenges.